Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments

Teeguarden, JG; Hinderliter, PM; Orr, G; Thrall, BD; Pounds, JG

HERO ID

90879

Reference Type

Journal Article

Subtype

Erratum

Year

2007

Language

English

HERO ID 90879
Material Type Erratum
In Press No
Year 2007
Title Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments
Authors Teeguarden, JG; Hinderliter, PM; Orr, G; Thrall, BD; Pounds, JG
Journal Toxicological Sciences
Volume 97
Issue 2
Page Numbers 614
Abstract The rapid growth in the use of in vitro methods for nanoparticle toxicity assessment has proceeded with limited consideration of the unique kinetics of these materials in solution. Particles in general and nanoparticles specifically, diffuse, settle, and agglomerate in cell culture media as a function of systemic and particle properties: media density and viscosity and particle size, shape, charge and density, for example. Cellular dose then is also a function of these factors as they determine the rate of transport of nanoparticles to cells in culture. Here we develop and apply the principles of dosimetry in vitro and outline an approach for simulation of nanoparticle particokinetics in cell culture systems. We illustrate that where equal mass concentrations (mu g/ml) imply equal doses for dissimilar materials, the corresponding particle number or surface area concentration doses differ by orders of magnitude. More importantly, when rates of diffusional and gravitational particle delivery are accounted for, trends and magnitude of the cellular dose as a function of particle size and density differ significantly from those implied by "concentration" doses. For example, 15-nm silver nanoparticles appear similar to 4000 times more potent than micron-sized cadmium oxide particles on a cm(2)/ml media basis, but are only similar to 50 times more potent when differences in delivery to adherent cells are considered. We conclude that simple surrogates of dose can cause significant misinterpretation of response and uptake data for nanoparticles in vitro. Incorporating particokinetics and principles of dosimetry would significantly improve the basis for nanoparticle toxicity
Doi 10.1093/toxsci/kfm097
Wosid WOS:000243787800002
Is Certified Translation No
Dupe Override No
Comments ECRIB. See 90287.Toxicol. Sci. 97: 614.
Is Public Yes
Language Text English
Keyword nanomaterial; kinetics; dosimetry; in vitro; risk assessment; settling; agglomeration; diffusion
Relationship(s)